Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
FLUCELVAX (Seqirus Pty Ltd)
Product name
FLUCELVAX
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
180 (255 working days)
Active ingredients
Influenza virus haemagglutinin
Registration type
NCE/NBE
Indication
For the prevention of influenza caused by Influenza Virus, Types A and B contained in the vaccine. The vaccine is indicated for use in adults and children 6 months of age and older.